(Q41096904)

26 September 2017

title

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset (English)

1 reference

Middle East respiratory syndrome coronavirus

26 September 2017

main subject

0 references

1 reference

1 reference

1 reference

1

1 reference

26 September 2017

Man-Lung Yeung

3

0 references

Honglin Chen

Honglin Chen

14

0 references

Hin Chu

Hin Chu

12

0 references

Jie Zhou

Jie Zhou

13

0 references

Yuen Kwok-yung

Kwok-Yung Yuen

16

0 references

Chuan Qin

15

Chuan Qin

1 reference

26 September 2017

5

Linlin Bao

1 reference

26 September 2017

4

Wei Deng

1 reference

26 September 2017

11

Jian-Piao Cai

1 reference

26 September 2017

2

Yanfeng Yao

1 reference

26 September 2017

6

Lilong Jia

1 reference

26 September 2017

Fengdi Li

7

1 reference

26 September 2017

Chong Xiao

8

1 reference

26 September 2017

Hong Gao

9

1 reference

26 September 2017

Pin Yu

10

1 reference

26 September 2017

language of work or name

English

0 references

publication date

21 July 2015

1 reference

Journal of Infectious Diseases

26 September 2017

published in

1 reference

26 September 2017

volume

212

1 reference

26 September 2017

issue

12

1 reference

26 September 2017

page(s)

1904-1913

1 reference

Interspecies transmission and emergence of novel viruses: lessons from bats and birds

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Use of convalescent plasma therapy in SARS patients in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Development and Evaluation of Novel Real-Time Reverse Transcription-PCR Assays with Locked Nucleic Acid Probes Targeting Leader Sequences of Human-Pathogenic Coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Construction of a novel SHIV having an HIV-1-derived protease gene and its infection to rhesus macaques: a useful tool for in vivo efficacy tests of protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Rapid generation of a mouse model for Middle East respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

MERS CoV infection in two renal transplant recipients: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

HIV protease inhibitors impact on apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV392

Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26198719

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIV392

1 reference

26 September 2017

0 references

1 reference